Nano-therapeutics for the lung: State-of-the-art and future perspectives

Roshni Iyer, Connie C W Hsia, Kytai T. Nguyen

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used as carriers to facilitate drug uptake and intracellular action in order to treat lung diseases and/or to facilitate lung repair and growth. These include polymeric nanoparticles, liposomes, and dendrimers, among many others. In addition, nanoparticles are sometimes used in combination with small molecules, cytokines, growth factors, and/or pluripotent stem cells. Here we review the rationale and state-of-the-art nanotechnology for pulmonary drug delivery, with particular attention to new technological developments and approaches as well as the challenges associated with them, the emerging advances, and opportunities for future development in this field.

Original languageEnglish (US)
Pages (from-to)5233-5244
Number of pages12
JournalCurrent Pharmaceutical Design
Volume21
Issue number36
StatePublished - Oct 1 2015

Fingerprint

Nanoparticles
Lung
Dendrimers
Pluripotent Stem Cells
Nanotechnology
Liposomes
Pharmaceutical Preparations
Inhalation
Lung Diseases
Intercellular Signaling Peptides and Proteins
Therapeutics
Cytokines
Growth

Keywords

  • Aerosolization
  • Growth factors
  • Inhalation
  • Lung disease
  • Lung repair
  • Nanoparticles
  • Pulmonary delivery
  • Stem cells

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Nano-therapeutics for the lung : State-of-the-art and future perspectives. / Iyer, Roshni; Hsia, Connie C W; Nguyen, Kytai T.

In: Current Pharmaceutical Design, Vol. 21, No. 36, 01.10.2015, p. 5233-5244.

Research output: Contribution to journalArticle

@article{535393a70ef14c6ea87effe0ed8b7b54,
title = "Nano-therapeutics for the lung: State-of-the-art and future perspectives",
abstract = "Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used as carriers to facilitate drug uptake and intracellular action in order to treat lung diseases and/or to facilitate lung repair and growth. These include polymeric nanoparticles, liposomes, and dendrimers, among many others. In addition, nanoparticles are sometimes used in combination with small molecules, cytokines, growth factors, and/or pluripotent stem cells. Here we review the rationale and state-of-the-art nanotechnology for pulmonary drug delivery, with particular attention to new technological developments and approaches as well as the challenges associated with them, the emerging advances, and opportunities for future development in this field.",
keywords = "Aerosolization, Growth factors, Inhalation, Lung disease, Lung repair, Nanoparticles, Pulmonary delivery, Stem cells",
author = "Roshni Iyer and Hsia, {Connie C W} and Nguyen, {Kytai T.}",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "21",
pages = "5233--5244",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "36",

}

TY - JOUR

T1 - Nano-therapeutics for the lung

T2 - State-of-the-art and future perspectives

AU - Iyer, Roshni

AU - Hsia, Connie C W

AU - Nguyen, Kytai T.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used as carriers to facilitate drug uptake and intracellular action in order to treat lung diseases and/or to facilitate lung repair and growth. These include polymeric nanoparticles, liposomes, and dendrimers, among many others. In addition, nanoparticles are sometimes used in combination with small molecules, cytokines, growth factors, and/or pluripotent stem cells. Here we review the rationale and state-of-the-art nanotechnology for pulmonary drug delivery, with particular attention to new technological developments and approaches as well as the challenges associated with them, the emerging advances, and opportunities for future development in this field.

AB - Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used as carriers to facilitate drug uptake and intracellular action in order to treat lung diseases and/or to facilitate lung repair and growth. These include polymeric nanoparticles, liposomes, and dendrimers, among many others. In addition, nanoparticles are sometimes used in combination with small molecules, cytokines, growth factors, and/or pluripotent stem cells. Here we review the rationale and state-of-the-art nanotechnology for pulmonary drug delivery, with particular attention to new technological developments and approaches as well as the challenges associated with them, the emerging advances, and opportunities for future development in this field.

KW - Aerosolization

KW - Growth factors

KW - Inhalation

KW - Lung disease

KW - Lung repair

KW - Nanoparticles

KW - Pulmonary delivery

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84947998428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947998428&partnerID=8YFLogxK

M3 - Article

C2 - 26412358

AN - SCOPUS:84947998428

VL - 21

SP - 5233

EP - 5244

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 36

ER -